{"id":"https://openalex.org/W337443539","doi":null,"title":"Everyone wants in, but with no ground rules, the biosimilar business remains elusive.","display_name":"Everyone wants in, but with no ground rules, the biosimilar business remains elusive.","publication_year":2011,"publication_date":"2011-01-01","ids":{"openalex":"https://openalex.org/W337443539","mag":"337443539","pmid":"https://pubmed.ncbi.nlm.nih.gov/22479217","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3278118"},"language":"en","primary_location":{"id":"pmh:oai:pubmedcentral.nih.gov:3278118","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3278118","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biotechnol Healthc","raw_type":"Text"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3278118","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"John Carroll","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"John Carroll","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.6223,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.8833353,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":94,"max":96},"biblio":{"volume":"8","issue":"3","first_page":"12","last_page":"3"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.8467000126838684,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.8467000126838684,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.14900000393390656,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/biosimilars","display_name":"biosimilars","score":0.9959999918937683},{"id":"https://openalex.org/keywords/cancer-drug-costs","display_name":"cancer drug costs","score":0.8009999990463257},{"id":"https://openalex.org/keywords/drug-pricing","display_name":"drug pricing","score":0.5809999704360962},{"id":"https://openalex.org/keywords/pharmacy-benefit-managers","display_name":"pharmacy benefit managers","score":0.6019999980926514},{"id":"https://openalex.org/keywords/drug-spending","display_name":"drug spending","score":0.38100001215934753},{"id":"https://openalex.org/keywords/cancer-survivors","display_name":"cancer survivors","score":0.546999990940094},{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":0.800000011920929},{"id":"https://openalex.org/keywords/imatinib","display_name":"imatinib","score":0.9959999918937683},{"id":"https://openalex.org/keywords/medicare-part-d","display_name":"Medicare Part D","score":0.39100000262260437},{"id":"https://openalex.org/keywords/drug-utilization-monitoring","display_name":"drug use monitoring","score":0.328000009059906}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6192806363105774},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5463772416114807},{"id":"https://openalex.org/C59491497","wikidata":"https://www.wikidata.org/wiki/Q864715","display_name":"Biosimilar","level":2,"score":0.5250139832496643},{"id":"https://openalex.org/C3020340455","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Cancer drugs","level":3,"score":0.5135186314582825},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.4804215431213379},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.4162663519382477},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.3514938950538635},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.32501697540283203},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.13929316401481628},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.1212485134601593},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"pmh:oai:pubmedcentral.nih.gov:3278118","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3278118","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biotechnol Healthc","raw_type":"Text"},{"id":"pmid:22479217","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22479217","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biotechnology healthcare","raw_type":"Journal Article"},{"id":"mag:337443539","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22479217","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:3278118","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3278118","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biotechnol Healthc","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.6240000128746033,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2006502925","https://openalex.org/W7170688704","https://openalex.org/W2332148629","https://openalex.org/W4410809943","https://openalex.org/W4313212491","https://openalex.org/W4401199722","https://openalex.org/W2779550906","https://openalex.org/W2407658018","https://openalex.org/W3193338657","https://openalex.org/W3024640726"],"abstract_inverted_index":{"When":[0],"Medco":[1,142],"published":[2],"its":[3,19],"annual":[4],"report":[5],"on":[6,21],"the":[7,13,22,75,86,101,109,164,184,191,206,224,255,267],"dominant":[8],"trends":[9],"in":[10,74,82,100,122,126,199,208,281],"drug":[11,28,124],"spending,":[12],"pharmacy":[14],"benefit":[15],"manager":[16],"swiftly":[17],"turned":[18],"spotlight":[20],"impact":[23],"of":[24,111,156,176,223,231,261,275],"rapidly":[25],"rising":[26],"cancer":[27,42,69,98,123,129,160,181],"costs.\r\n\r\nCancer":[29],"detection":[30],"is":[31],"getting":[32],"better":[33],"than":[34,52,95,170],"ever,":[35],"says":[36],"Medco.":[37],"As":[38],"a":[39,63,118,173,196,200,209,258],"result,":[40],"more":[41,50,94,169],"patients":[43],"are":[44,137,240],"living,":[45],"living":[46,73],"longer,":[47],"and":[48,134,146,221,247],"requiring":[49],"treatment":[51],"ever":[53],"before.":[54],"By":[55],"2020,":[56],"that":[57,115,202,211],"trend":[58],"will":[59,71,104,182],"lead":[60],"us":[61],"to":[62,108,213,242,244,264,269],"day":[64],"when":[65],"some":[66],"18":[67],"million":[68,81],"survivors":[70],"be":[72,105],"United":[76],"States,":[77],"up":[78],"from":[79],"13.8":[80],"2010.":[83],"And":[84,153],"over":[85,163],"next":[87],"few":[88],"years,":[89],"developers":[90],"\u2014":[91,103,205,220],"who":[92],"list":[93,110],"900":[96],"new":[97,159,259],"drugs":[99,130,161,263],"pipeline":[102],"adding":[106],"significantly":[107],"specialty":[112],"oncology":[113],"therapeutics":[114],"helped":[116],"trigger":[117],"21.2":[119],"percent":[120],"hike":[121],"expenditures":[125],"2010":[127],"alone.1\r\n\r\nPricey":[128],"like":[131],"lenalidomide":[132],"(Revlimid)":[133],"imatinib":[135],"(Gleevec)":[136],"becoming":[138],"increasingly":[139],"popular,":[140],"notes":[141],"Senior":[143],"Vice":[144],"President":[145],"Chief":[147],"Medical":[148],"Officer":[149],"Glenn":[150],"Stettin,":[151],"MD.":[152],"9":[154],"out":[155],"every":[157],"10":[158],"approved":[162],"past":[165],"seven":[166],"years":[167],"cost":[168,188],"$20,000":[171],"for":[172,278],"12-week":[174],"course":[175],"treatment.":[177],"In":[178],"this":[179],"scenario,":[180],"become":[183],"second-":[185],"or":[186],"third-leading":[187],"driver":[189],"among":[190],"top":[192],"three":[193],"diseases,":[194],"taking":[195],"prominent":[197],"place":[198],"mix":[201],"includes":[203],"diabetes":[204],"leader":[207],"country":[210,256],"continues":[212],"get":[214,228],"fatter":[215],"at":[216],"an":[217],"alarming":[218],"pace":[219],"diseases":[222],"central":[225],"nervous":[226],"system.\r\n\r\nTo":[227],"any":[229],"kind":[230],"short-term":[232],"price":[233],"relief,":[234],"Stettin":[235],"tells":[236],"Biotechnology":[237],"Healthcare,":[238],"payers":[239],"going":[241],"have":[243],"monitor":[245],"dosages":[246],"overall":[248],"usage":[249],"carefully.":[250],"Longer":[251],"term,":[252],"he":[253],"says,":[254],"needs":[257],"generation":[260],"biosimilar":[262],"come":[265,285],"onto":[266],"market":[268],"reduce":[270],"costs.":[271],"This":[272],"last":[273],"part":[274],"Medco\u2019s":[276],"prescription":[277],"keeping":[279],"spending":[280],"check,":[282],"though,":[283],"won\u2019t":[284],"easy.":[286]},"counts_by_year":[{"year":2013,"cited_by_count":2}],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2016-06-24T00:00:00"}